ISRACANN Biosciences: Invest in Israel’s First Cannabis Pure-Play Public Offering
Ryan Allway April 4th, 2019 Exclusive, News, Top Story North America may be capturing most of the headlines when it comes to the cannabis industry, but other global cannabis frontier markets could offer greater growth potential. Israel is already well-known as the cannabis research capital of the world. Similarly,... Read more
Cansortium: Multi-State Cannabis Operator Trading on CSE
Tony Deyes April 2nd, 2019 Exclusive, News, Top Story As a strategic first-mover in regulated markets with high barriers to entry, including Florida, Texas, Pennsylvania and Puerto Rico, Miami-based Cansortium (CSE: TIUM) aims to redefine the standard for the medical cannabis industry. The company is a cultivator, processor, formulator... Read more
FSD Pharma Promotes New Leadership & Advances Projects
Ryan Allway April 1st, 2019 Exclusive, News Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis last year and the upcoming legalization of oils, concentrates and edibles. Investors have many opportunities in the space, but... Read more
Westleaf Partners With Xabis Ahead of Derivative Products Legalization
Tony Deyes March 22nd, 2019 Exclusive, News, Top Story Calgary-based Westleaf Inc. (TSX-V: WL) has entered into an exclusive partnership with a Colorado cannabis processing company providing turnkey extraction and cannabis-infused derivative product manufacturing solutions. Under the agreement, Xabis Inc, an industry leader in the design, construction, and management... Read more
The Science Behind Medical Marijuana is Flawed
Robin Lefferts March 21st, 2019 Exclusive, News, Top News To hear some advocates talk about it, cannabis is a miracle drug, capable of treating everything from chronic pain, nausea, chemotherapy side effects, muscle spasms, multiple sclerosis, and more. And it’s true. Medical marijuana and cannabidiol (CBD) have been used... Read more
Why Cannabis Concentrates Are a Big Deal for Investors
Ryan Allway March 19th, 2019 Exclusive, News, Top Story The term “concentrate” is widely used across the cannabis industry, but the definition is ambiguous since it encompasses any product procured through an extraction process. While hash and shatter have been staples of the cannabis industry for years, new extraction... Read more
BLOCKStrain: Three Target Markets, One Breakthrough Platform
Ryan Allway March 19th, 2019 Exclusive, News, Top News The global cannabis industry is projected to reach nearly $150 billion by 2025, according to Grand View Research, as a growing number of governments legalize marijuana. While legalization has created an overnight multi-billion dollar market for investors, consumers, cultivators, and... Read more
Canada’s Cannabis Industry Looks Global for Growth
Ryan Allway March 8th, 2019 Exclusive, News, Top Story Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis last year. With the legalization of edibles later this year, the market could attract an even... Read more
CFN Media Exclusive Q&A with KlickTrack COO, Co-Founder
Rachelle Gordon March 1st, 2019 Exclusive, News While the cannabis industry may still be in its infancy, the retail marketplace is already experiencing a revolution unlike anything we have ever seen. The need for seamless compliance, efficient sales tracking, and intuitive customer loyalty is at an all-time high and... Read more
Yield Growth’s Urban Juve Takes a Fresh Approach to Skincare
Ryan Allway March 1st, 2019 Exclusive, News, Top Story Most cannabis investors are focused on the medical and recreational cannabis markets, but many ancillary markets are experiencing equally impressive growth. While cannabis industry could hit nearly $150 billion over the coming years, the global wellness industry is already worth upwards... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )